chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 1.25
Sex: M
Vaccine: MMR, PNC13
Symptoms: Febrile convulsion, Influenza A virus test negative, Influenza B virus test, Pyrexia, Respiratory syncytial virus test negative
Clinical narrative: In the evening of the day he received the immunizations, child had fever which led to a febrile seizure and ER visit.
Age: 1.25
Sex: M
Vaccine: MMR, PNC13
Symptoms: SARS-CoV-2 test negative
Clinical narrative: In the evening of the day he received the immunizations, child had fever which led to a febrile seizure and ER visit.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angiogram normal, Blood test normal, Electrocardiogram normal, Ischaemic stroke, Magnetic resonance imaging normal
Clinical narrative: Within 48 hours of the second shot I had 4 ischemic strokes. Treatment is ongoing with occupation therapy (vision), speech therapy and potential for physical therapy.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Venogram normal
Clinical narrative: Within 48 hours of the second shot I had 4 ischemic strokes. Treatment is ongoing with occupation therapy (vision), speech therapy and potential for physical therapy.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Respiratory tract congestion
Clinical narrative: Congestion, cough.  Starting 1/6/22.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Accidentally gave Moderna vax instead of Pfizer to a 16year old. Parent authorized to be boosted vaccinated by facility since the minor works. No adverse effects noted.  Just usual side effects after vaccination.
Age: 16.0
Sex: M
Vaccine: MNQ
Symptoms: Chest discomfort, Chest pain, Dyspnoea
Clinical narrative: About one hour after receiving the shot, he began to have difficulty breathing and tightness in chest.  He did not alert his mother until later that night around 7 pm.  Mother monitored as they were not at home. On his way home, he had a brief period of chest pain of about 10 minutes which then stopped, but the difficulty breathing continued.  The mother called a nurse practitioner friend that advised to listen for crackling sounds or congestion in lungs, the mother did and lungs sounded clear.  NP friend suggested that the mother give Benadryl and monitor through the night (the mother did not want to go to a hospital setting if she could avoid it due to crowded waiting rooms and potential covid exposure). The difficulty breathing went away within an hour and did not return.  Mother continually checked on son during that night and the following days - symptoms did not return. Mother called the dr's office the next week and is awaiting information on if more testing is needed for the reaction.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Patient received a vaccine about 40 hours post dilution. Pfizer had stability data for 24 hours post vaccination and suggested to as for recommendation from CDC. After consulting CDC medical team, the recomendation was given to vaccinate patient ASAP. Patient came to the pharmacy same day and got revaccinated.
Age: 45.0
Sex: U
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19
Clinical narrative: Asymptomatic
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chest pain, Dyspnoea, Lymphadenopathy, Throat tightness
Clinical narrative: I got my third dose of the vaccine in Pfizer. When I got the first two doses of Moderna I had Migraines and chest pain as well as shortness of breath. I waited for 60 minutes after my shot. Within two hours I had a headache. I tried some Tylenol but within 3 hours the whole left side of my head hurt. I took 25mg of Tramadol and had to take more and then the headache was better. My lymph nodes were very swollen underneath my arm and in my neck. I was still getting ear pain and my lymph nodes were swollen and tender on the left side. It was the same side as I got the vaccine. They were still swollen when I got the second dose and stayed enlarged for about six months. The headaches persisted for as long as the Lymph Nodes were very swollen during the first month. If I stayed ahead of the pain with Tylenol and Motrin the pain stayed under control. I was also fatigued for a long time. After getting the third dose of the vaccine I experienced the chest pain and pressure on my chest. I was short of breath also. It was the same kind of pain I had gotten with the first dose but the shortness of breath and chest pain were much worse. I had taken Tylenol and Motrin this time but the headache stayed under control. All Cardiac testing was negative at the ER. My lymph nodes are so swollen it feels like my throat is a little constricted.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Pediatric Pfizer Covid vaccine administered for pt 12 years old (outside of indicated age range 5-11 years)
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: patient reported today that she had a full body rash that was unresolved with benadryl and topical antihistamine/steroid.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Blister, Discomfort, Fatigue, Headache
Clinical narrative: On 7Jan2022, I was awoken in the middle of the neck with severe pain around my right hip.  On 8Jan2022, I noticed a line of red raised rash above my right hip bone.  It started in the back and came across my abdomen.  I also experienced fatigue and headache.  on 9Jan2022, the original line of raised rash developed blisters and I had new red raised rash on the right side of my back.  Severe pain and discomfort occuring.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Pain, Rash erythematous, Rash papular, Sleep disorder
Clinical narrative: On 7Jan2022, I was awoken in the middle of the neck with severe pain around my right hip.  On 8Jan2022, I noticed a line of red raised rash above my right hip bone.  It started in the back and came across my abdomen.  I also experienced fatigue and headache.  on 9Jan2022, the original line of raised rash developed blisters and I had new red raised rash on the right side of my back.  Severe pain and discomfort occuring.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Ear infection, Eustachian tube dysfunction, Musculoskeletal discomfort, Tinnitus
Clinical narrative: Tinnitus started occurring on April 12 which is roughtly about 1 1/2 week after vaccine.  Went to doctor who prescribed azithromycin assuming it was an ear infection but problem did not resolve.  Went to see ENT who mentioned it could be Eustachian Tube Dysfunction and prescribed Fluticasone Propianate for a month which also did not resolve the tinnitus.   Also around this time frame been having a shoulder issue that also has not resolve on the left side where I had the 2nd shot.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Respiratory tract congestion, SARS-CoV-2 test positive, Sneezing
Clinical narrative: 3-4 days of mild cough, mild congestion, sneezing, itchy throat (1/4 to 1/7). Treated with generic OTC cold symptom relief medication
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Throat irritation
Clinical narrative: 3-4 days of mild cough, mild congestion, sneezing, itchy throat (1/4 to 1/7). Treated with generic OTC cold symptom relief medication
Age: 59.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Abdominal distension, Fatigue, Influenza, Intermenstrual bleeding, Muscle spasms
Clinical narrative: I'm not sure of the Flu shot so I just checked the top one.  I had both shots the same day.  By the next morning I felt like I had the flu and was extremely tired.  I also started experiencing menstrual  cycle symptoms.  I had bloating, cramps, headache and spotting for 5 days.  Almost exactly a month later it came back and I had spotting for 8 days.  My doctor was contacted (not my primary but my Nurse Practitioner) and she suggested I let her know if it continues.  After the second month they made an appointment to do another PAP.  I have not had a period in 15 years.  This happened the next day after my 3rd shot which is too coincidental.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chest pain, Headache, Migraine, Nausea
Clinical narrative: It felt like my heart was in a vice grip, chest pain starting middle of the night day I received the vaccine. Restless, unable to sleep. Sat upright in a recliner most of the night. It felt like my heart was racing, chest pain, headache and arm ached. I continued to experience migraines and nausea for almost a week post vaccination. Peaking the Sunday following.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Palpitations, Restlessness, Sleep disorder
Clinical narrative: It felt like my heart was in a vice grip, chest pain starting middle of the night day I received the vaccine. Restless, unable to sleep. Sat upright in a recliner most of the night. It felt like my heart was racing, chest pain, headache and arm ached. I continued to experience migraines and nausea for almost a week post vaccination. Peaking the Sunday following.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heavy menstrual bleeding, Menstruation irregular, Muscle spasms
Clinical narrative: One week after receiving my 2nd vaccine, I got my period, which was not on schedule with when I should have. It lasted continually for 7 months. I dod not have any history of irregular periods prior to this. On the same day that my period began, I also had a severe Charlie horse cramp in my left foot and calf muscle. For the next 7 months I had severe cramps in my left leg and foot every 3-4 days. I did not have any prior history of this. The leg cramps and my period began on the first day, continued for 7 months and both ended on the same day.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Allergy test, Allergy to chemicals, Eye swelling, Hypersensitivity, Lip swelling
Clinical narrative: A week after I got the vaccine, I started having random allergic reactions. My lips or eyes would swell almost shut, and I had hives everywhere. This was 8 months ago and since then I have been having allergic reactions every 3 days. I?ve been put on so much medication but absolutely nothing helps. I have never ever had this problem before no allergies nothing until a week after my vaccine. I?ve been in touch with a ton of people online who have this exact same issue as I do, photo evidence and all. I can provide about 60 photos of what the past 8 months of my life looks like. I am sad and scared that this will be permanent. I can barely leave my house.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: A week after I got the vaccine, I started having random allergic reactions. My lips or eyes would swell almost shut, and I had hives everywhere. This was 8 months ago and since then I have been having allergic reactions every 3 days. I?ve been put on so much medication but absolutely nothing helps. I have never ever had this problem before no allergies nothing until a week after my vaccine. I?ve been in touch with a ton of people online who have this exact same issue as I do, photo evidence and all. I can provide about 60 photos of what the past 8 months of my life looks like. I am sad and scared that this will be permanent. I can barely leave my house.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Sensation of foreign body
Clinical narrative: 01/04 After experiencing this "lump" in my throat for a few days I decided to contact my PCP and was set up a meeting where I was checked for Covid at the door on 01/05. After a couple of days, was informed I had Covid and was order quarantined for 5 days and had to wear a mask after. Was informed to keep a hot compress on lump and if got worse to call back. Also, advised not to get a mammogram.
Age: 10.0
Sex: M
Vaccine: FLU4, HPV9, TDAP
Symptoms: Dizziness, Hyperhidrosis, Nausea, Pallor
Clinical narrative: Child felt nauseous, dizzy, was sweaty and pale for 5 minutes and then recovered.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site mass, Injection site pain, Injection site swelling
Clinical narrative: Small lump developed at the injection site within a week of receiving dose #2. Approximately 6 months after receiving the second dose the lump remains at the injection site and has become enlarged and tender to the touch.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebrovascular accident, Deep vein thrombosis, Imaging procedure abnormal, Ultrasound Doppler abnormal
Clinical narrative: 10 days after pt received the pfizer covid booster he sustained a stroke and  a DVT.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient requested the first dose of the Moderna COVID-19 vaccination. Received vaccination even though patient is 17 years old (under the recommended age for Moderna).
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Discomfort, Pruritus, Rash, Urticaria
Clinical narrative: About 12 days after vaccination, severe hives and rashes appeared all over body. Extreme discomfort and itchiness all over body. Hives and rashes tend to appear on upper thighs, groin, stomach, around armpits, chest, back, wrists/hands, feet, knees.
Age: 17.0
Sex: F
Vaccine: COVID19, FLUC4
Symptoms: Loss of consciousness, Pallor, Seizure, Tongue biting
Clinical narrative: Patient lost consciousness as observed by accompanying guardian. Per guardian, patient also had a short seizure and skin color turned pale. Episode lasted less than 1 minute. Pharmacist was alerted but patient already regained consciousness and did not need epinephrine or interventions. Recommended patient lower head in seated position to increase blood flow. Patient also bit tongue during episode. Recommended patient stay for another 15 minutes for observation. Followed up with guardian on Monday 1/10/22 and no further incidents reported.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Heavy menstrual bleeding, Menstruation irregular, Muscle spasms, Oligomenorrhoea
Clinical narrative: Abnormally heavy menstrual cycles that last 8+ days (used to last 5-6 days). Heavy clotting spells that last hours, leading to lightheadedness/the verge of fainting. Bleeding through heavy duty tampons in less than an hour. Extreme breakouts on chin, about 10-20 blemishes when approaching menstrual cycle. Severe cramping, doubled over in pain when approaching menstrual cycle/on menstrual cycle. Period is now either early or late, never on time like it had been since I was 13 (I'm now 30).
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Skin reaction, Thrombosis
Clinical narrative: Abnormally heavy menstrual cycles that last 8+ days (used to last 5-6 days). Heavy clotting spells that last hours, leading to lightheadedness/the verge of fainting. Bleeding through heavy duty tampons in less than an hour. Extreme breakouts on chin, about 10-20 blemishes when approaching menstrual cycle. Severe cramping, doubled over in pain when approaching menstrual cycle/on menstrual cycle. Period is now either early or late, never on time like it had been since I was 13 (I'm now 30).
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain lower, Appendicectomy, Appendicitis, Appendicolith, Computerised tomogram abdomen abnormal
Clinical narrative: Appendicitis on 6/5/2021 requiring appendectomy on 6/5/2021.  Presenting symptoms on 6/5/2021 were right lower quadrant abdominal pain, vomiting, and low grade fever.
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Full blood count normal, Neutrophil percentage increased, Pathology test, Pyrexia, Vomiting
Clinical narrative: Appendicitis on 6/5/2021 requiring appendectomy on 6/5/2021.  Presenting symptoms on 6/5/2021 were right lower quadrant abdominal pain, vomiting, and low grade fever.
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: White blood cell count increased
Clinical narrative: Appendicitis on 6/5/2021 requiring appendectomy on 6/5/2021.  Presenting symptoms on 6/5/2021 were right lower quadrant abdominal pain, vomiting, and low grade fever.
Age: 48.0
Sex: F
Vaccine: FLUA4
Symptoms: Wrong product administered
Clinical narrative: Was given in error the Fluad influenza vaccine instead of the FluLaval vaccine.
Age: 45.0
Sex: M
Vaccine: COVID19, FLUC4
Symptoms: Eye swelling, Pain in extremity, Pruritus, Rash, SARS-CoV-2 test negative
Clinical narrative: On January 7th, 2022, 11 days after the flu and COVID vaccines were administered; I began to notice an uncontrollable itch in my groin area as well as shoulders and head.  The itch became more severe throughout the day and hives began to appear along with rashes.  These were at various locations on my body.  I began to develop an uncontrollable itch and pain in the palms of my hands.  Later that day I took a benadryl tablet which alleviated some of the itchiness.  By that evening I noticed distinct hives developing around the outside of my face, jawline, temple, shoulders and neck.  My eyes began to swell.  The next day, January 8th, 2022, I visited the local urgent care facility.  My body and face still covered in hives and rash.  My jaw and neck began to swell at this point from my temples down.  I was given a COVID rapid test which was NEGATIVE.  The physician felt this was a result of a delayed reaction from the vaccine.  I was prescribed a methylprednisolone dosepak (6 days, series of 4mg tablets) and began taking Zyrtec for the itch.  after  2 days taking the prescribed medication I began to notice less rash and hives.  The swelling began to subside after the second day and the itching is almost irrelevant.  At this time (January 10th, 2022) I am noticing sporadic rash activity in different parts of my body but with very limited duration.  The itchiness is almost completely gone and the swelling around my jam and neck is 90% resolved.
Age: 45.0
Sex: M
Vaccine: COVID19, FLUC4
Symptoms: Swelling, Swelling face, Type IV hypersensitivity reaction, Urticaria
Clinical narrative: On January 7th, 2022, 11 days after the flu and COVID vaccines were administered; I began to notice an uncontrollable itch in my groin area as well as shoulders and head.  The itch became more severe throughout the day and hives began to appear along with rashes.  These were at various locations on my body.  I began to develop an uncontrollable itch and pain in the palms of my hands.  Later that day I took a benadryl tablet which alleviated some of the itchiness.  By that evening I noticed distinct hives developing around the outside of my face, jawline, temple, shoulders and neck.  My eyes began to swell.  The next day, January 8th, 2022, I visited the local urgent care facility.  My body and face still covered in hives and rash.  My jaw and neck began to swell at this point from my temples down.  I was given a COVID rapid test which was NEGATIVE.  The physician felt this was a result of a delayed reaction from the vaccine.  I was prescribed a methylprednisolone dosepak (6 days, series of 4mg tablets) and began taking Zyrtec for the itch.  after  2 days taking the prescribed medication I began to notice less rash and hives.  The swelling began to subside after the second day and the itching is almost irrelevant.  At this time (January 10th, 2022) I am noticing sporadic rash activity in different parts of my body but with very limited duration.  The itchiness is almost completely gone and the swelling around my jam and neck is 90% resolved.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: Severe itching and breaking out in hives. Hives and itching move around body. This has lasted over a month.
Age: 73.0
Sex: M
Vaccine: UNK
Symptoms: Arthralgia
Clinical narrative: Continued Pain is my shoulder from the tetanus vaccination
Age: 56.0
Sex: F
Vaccine: FLUA4
Symptoms: Wrong product administered
Clinical narrative: Was given in error the  Fluad influenza vaccine instead of the FluLaval vaccine.
Age: 11.0
Sex: M
Vaccine: FLU4, MNQ
Symptoms: Dizziness, Fatigue, Hyperhidrosis, Nausea, Tongue discomfort
Clinical narrative: child became dizzy and nauseated. He was sweating and tired.  He mentioned that his tongue felt weird but was normal on exam and no difficulty swallowing or breathing. Improved on laying down and drinking  fluids.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: PATIENT WAS GIVEN BOOSTER DOSE SOON THAN RECOMMENED
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Rash pruritic
Clinical narrative: The evening of 1/9/2022 the patient began experiencing an itchy rash on her neck and head. Over the next 24 hours she developed itchy spots over her whole body. Her sister received the same vaccine (pfizer booster) and was experiencing similar symptoms with the same timetable. The patient did not have any issues with the first two vaccines; she also reported starting to use a new body lotion within the two weeks prior to the symptoms starting.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, Fatigue, Nausea, Pain
Clinical narrative: Elevated temperature, nauseated, fatigued, aches.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: The patient made the appt saying he wanted his first dose of Moderna. He filled out the moderna consent form. He never presented a vaccination card. I asked him prior to giving the shot if this was his first dose of Moderna. He said, yes. I told him he would need a second appt 4 weeks from now which would be February 7th 2022. He said ok. Prior to administering the vaccine I told he he needed to wait for 15 minutes after I gave the shot in case something were to happen. He said ok. I told him I'd write up his vaccine card and hand it to him after 15 min.  He said ok.  About 10 minutes later he comes and asks me if he received the booster dose.  Then shows me his vaccine card.   I am reporting this mainly because he received a 3rd full dose of 0.5ml of Moderna, rather than the 0.25ml booster dose.    His primary series wasn't done according to protocol either. It was NOT administered at our pharmacy. I took the information from Information System.  1st Moderna 0.5ml  1/20/21 2nd Pfizer 0.3ml  2/18/2021  3rd dose (full dose) 01/10/2022  This vaccine history was obtained after the fact.
Age: 17.0
Sex: F
Vaccine: UNK
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Pt was given a Pfizer booster vaccine sooner than  the recommended time of 5month. 2nd dose was administered on 11/7/21. Pt made an appt. online for a booster dose for 1/10/2022. Vaccine was administered
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic
Clinical narrative: At 2PM 1/9/2022 the patient began experiencing an itchy rash on her torso. Over the next 24 hours she developed itchy spots over her whole body. Her sister received the same vaccine (pfizer booster) and was experiencing similar symptoms with the same timetable. The patient did not have any issues with the first two vaccines; she also reported starting to use a new body lotion within the two weeks prior to the symptoms starting.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Flushing, Hyperhidrosis, Syncope
Clinical narrative: patient passed out multiple times, 4 total.  Patient felt flush and sweaty when he came back.  Episode lasted about 30 minutes
Age: 56.0
Sex: F
Vaccine: FLUA4
Symptoms: Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: Patient was given in error the Fluad vaccine instead of the Flulaval vaccine.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Patient is a 12 year old male and should have received his second dose of the Pfizer vaccine for ages 12 and above. Instead the patient received a dose of the Pfizer formulation for ages 5-11. There was no reported adverse event. The parents were notified of the administration of the incorrect vaccine formulation and that the patient received a smaller than intended dose. After consulting with the manufacturer the provider recommends that the child come back to complete the intended series in 21 days. Parents are in agreement.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was given past the beyond use date of 01/02/2022. Incident report has been submitted
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Laboratory test abnormal, Pruritus, Rash, White blood cell count increased
Clinical narrative: Intermittent Rash started about 2.5 days after first pfizer covid vaccine. Rash would appear for about an hour, then disappear completely. About a hour later it would reappear in a different location on the body. This repeated itself for about 3 days. PCP office was contacted on 12/30, pictures were sent for them to review. PCP advised Zyrtek 5-10 ml per day until rash was gone. Patient had itching and seemed fatigued.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: The client received the first dose of Moderna COVID vaccine (Lot#069H21A, exp: 04/06/2022). LVN checked the client's birthday prior to administering the vaccine. LVN noted the client was 17 years old after administration of the Moderna vaccine. RN The client did not report any symptoms during the 15 minute observation period.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient received booster dose too soon after 2nd dose.  2nd dose was given on September 3, 2021, and patient got booster on 01/10/22.
Age: 1.67
Sex: F
Vaccine: HEPA
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Dose # 2 given < 6 months after dose #1 Dose #1 received 8/18/2021
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was provided past the beyond use date of 01/02/2022, VAERS has been submitted
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on face
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding, Menstruation irregular, Muscle spasms, Thrombosis
Clinical narrative: 1 week after vaccine injection, I started my period 2 weeks early. I bled for a month. The first two weeks, I had an extremely heavy period.  5 of those days there was very heavy clotting with painful cramping. I had blood clots the size of half my fist come out in the shower. Too many to count. I clogged my drain. I was using 2 ultra tampons and a pad every hour. The bleeding continued to be heavy from weeks 2-4 but manageable.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was provided past the beyond use date of 01/02/2022, VAERS has been submitted
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was provided past the beyond use date of 01/02/2022, Incident report has been submitted
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain lower, Computerised tomogram abnormal, Ovarian cyst ruptured, Ultrasound scan abnormal
Clinical narrative: sharp lower abdominal pain, persistent pain for 2-3 days, went to er and found large complex liquid , diagnosed  as ruptured ovarian cyst
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Thrombosis, Ultrasound Doppler abnormal
Clinical narrative: Blood clot behind right knee  - now on blood thinners-symptoms gone
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was provided past the beyond use date of 01/02/2022, Incident report has been submitted
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Urticaria
Clinical narrative: Hives, chills, headache. OTC Benadryl and ibuprofen.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Patient had red arm and swollen at injection site. Painful to the touch and hot to the touch. It took place 3 days after her second dose and went away slowly over period of time.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was provided past the beyond use date of 01/02/2022, Incident report has been submitted
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Loss of consciousness
Clinical narrative: A few minutes after vaccination, patient said she needed to sit down. She sat on the floor and her mom grabbed her. She went unconscious for a few minutes. She was uninjured. We gave her water and chocolate and she was okay in 10 minutes.
Age: 20.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was provided past the beyond use date of 01/02/2022, Incident report has been submitted
Age: 17.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 17 year old patient was given 2 doses of moderna covid vaccine
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Polymerase chain reaction
Clinical narrative: Hospitalization due to COVID
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: Capillary fragility, Epistaxis, Headache, Malaise
Clinical narrative: Recurrent epistaxis over a 3 day period. ER doctor reported broken capillaries observed in sons right nostril to this writer up on assessment. He also experienced the common side effects which are made accessible to the public such as head ache and general malaise.  My son has no history of this.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Deafness, Tinnitus
Clinical narrative: Increased Tinnitus and hearing loss
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was provided past the beyond use date of 01/02/2022, Incident report has been submitted
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was provided past the beyond use date of 01/02/2022, Incident report has been submitted
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Joint swelling, Skin discolouration, Vaccine positive rechallenge
Clinical narrative: Painful, swollen and purplish ankles, which I never have any other time, but the same thing happened after my second shot in April 2021. The swelling started 10 days after my second shot and again 13 days after my booster.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Polymerase chain reaction
Clinical narrative: Hospitalization due to COVID
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was provided past the beyond use date of 01/02/2022, Incident report has been submitted
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was provided past the beyond use date of 01/02/2022, Incident report has been submitted
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm
Age: 58.0
Sex: F
Vaccine: COVID19, FLUC4
Symptoms: Nausea, Pyrexia, Sinus headache, Vomiting
Clinical narrative: Headache around sinus area (under eyebrows and teeth), slight fever of 99.1, nausea and vomiting.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was provided past the beyond use date of 01/02/2022, Incident report has been submitted
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Emotional disorder, Impaired work ability, Migraine, Social avoidant behaviour
Clinical narrative: Migraines that were previously under control have returned.  Experience migraine symptoms multiple times weekly.  Currently treating with over the counter medication and biofeedback techniques.  Outcomes:  slowing work productivity, increase in social/emotional withdrawal.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19 pneumonia
Clinical narrative: Acute respiratory failure with hypoxia due to COVID-19 pneumonia
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Need f/u pt was given undiluted dose. Called pt guardian with no response.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was provided past the beyond use date of 01/02/2022, Incident report has been submitted
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was provided past the beyond use date of 01/02/2022, Incident report has been submitted
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Intermenstrual bleeding, Menstruation delayed, Muscle spasms, Premenstrual syndrome
Clinical narrative: My last mensuration date before the vaccine was on October 5th, 2021. Before the vaccine it was between 29-32 day cycles, so my period was supposed to begin approximately beginning of November. I experienced spotting, very  painful cramps and heightened PMS symptoms around the end of October. My next period however did not arrive until November 14th. This cycle was 41 days.  For the next cycle it was very similar very painful cramps and heightened PMS symptoms around 1-2 weeks before my period began. This time my period started on 12/31/21, which was a 45 day cycle.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine provided past the beyond-use-date of 01/02/2022. Incident report submitted.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Activated partial thromboplastin time shortened, Alanine aminotransferase normal, Anion gap, Antibody test negative, Anticoagulant therapy
Clinical narrative: Patient hospitalized for 8 hours.  Patient is a 25yo female who presented at 34w0d with fever, tachycardia, and malaise. Given her symptoms a sepsis workup was completed and was given IV fluid resuscitation and oral tylenol. She was found to be positive for Covid 19. After her fluid resuscitation she felt much better. Her vital signs normalized with a heart rate of 88. The fetal heart rate on arrival was tachycardic in the 170's - this also resolved with fluid resuscitation to a baseline of 145-150, moderate variability, with +accels, no decels. She had a normal WBC count and her CBC and CMP were normal. She did report lower pelvic pain and urinary frequency, although denies dysuria or hematuria. A urinalysis was suspicious for a UTI so she was treated with 3gm fosfomycin. As she did not meet inpatient hospitalization criteria the monoclonal antibody team was consulted and she elected to receive the infusion. This was given while she was in triage. The patient was advised to return to the hospital with any alarming signs/sxs including severe chest pain, shortness of breath, severe abdominal pain or decreased fetal movement. We discussed quarantining due to Covid and will plan to reschedule her next prenatal visit. She was also taught to administer lovenox and was given her first dose of 40mg SQ. A rx was sent for 40mg BID for 10 days for DVT prophylaxis. She felt comfortable with the plan for discharge and had no further questions.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Aspartate aminotransferase normal, Bacterial test, Basophil count decreased, Basophil percentage decreased, Blood albumin decreased
Clinical narrative: Patient hospitalized for 8 hours.  Patient is a 25yo female who presented at 34w0d with fever, tachycardia, and malaise. Given her symptoms a sepsis workup was completed and was given IV fluid resuscitation and oral tylenol. She was found to be positive for Covid 19. After her fluid resuscitation she felt much better. Her vital signs normalized with a heart rate of 88. The fetal heart rate on arrival was tachycardic in the 170's - this also resolved with fluid resuscitation to a baseline of 145-150, moderate variability, with +accels, no decels. She had a normal WBC count and her CBC and CMP were normal. She did report lower pelvic pain and urinary frequency, although denies dysuria or hematuria. A urinalysis was suspicious for a UTI so she was treated with 3gm fosfomycin. As she did not meet inpatient hospitalization criteria the monoclonal antibody team was consulted and she elected to receive the infusion. This was given while she was in triage. The patient was advised to return to the hospital with any alarming signs/sxs including severe chest pain, shortness of breath, severe abdominal pain or decreased fetal movement. We discussed quarantining due to Covid and will plan to reschedule her next prenatal visit. She was also taught to administer lovenox and was given her first dose of 40mg SQ. A rx was sent for 40mg BID for 10 days for DVT prophylaxis. She felt comfortable with the plan for discharge and had no further questions.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Blood alkaline phosphatase increased, Blood bicarbonate decreased, Blood bilirubin decreased, Blood calcium decreased, Blood chloride normal
Clinical narrative: Patient hospitalized for 8 hours.  Patient is a 25yo female who presented at 34w0d with fever, tachycardia, and malaise. Given her symptoms a sepsis workup was completed and was given IV fluid resuscitation and oral tylenol. She was found to be positive for Covid 19. After her fluid resuscitation she felt much better. Her vital signs normalized with a heart rate of 88. The fetal heart rate on arrival was tachycardic in the 170's - this also resolved with fluid resuscitation to a baseline of 145-150, moderate variability, with +accels, no decels. She had a normal WBC count and her CBC and CMP were normal. She did report lower pelvic pain and urinary frequency, although denies dysuria or hematuria. A urinalysis was suspicious for a UTI so she was treated with 3gm fosfomycin. As she did not meet inpatient hospitalization criteria the monoclonal antibody team was consulted and she elected to receive the infusion. This was given while she was in triage. The patient was advised to return to the hospital with any alarming signs/sxs including severe chest pain, shortness of breath, severe abdominal pain or decreased fetal movement. We discussed quarantining due to Covid and will plan to reschedule her next prenatal visit. She was also taught to administer lovenox and was given her first dose of 40mg SQ. A rx was sent for 40mg BID for 10 days for DVT prophylaxis. She felt comfortable with the plan for discharge and had no further questions.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Blood creatinine normal, Blood culture negative, Blood glucose normal, Blood grouping, Blood magnesium normal
Clinical narrative: Patient hospitalized for 8 hours.  Patient is a 25yo female who presented at 34w0d with fever, tachycardia, and malaise. Given her symptoms a sepsis workup was completed and was given IV fluid resuscitation and oral tylenol. She was found to be positive for Covid 19. After her fluid resuscitation she felt much better. Her vital signs normalized with a heart rate of 88. The fetal heart rate on arrival was tachycardic in the 170's - this also resolved with fluid resuscitation to a baseline of 145-150, moderate variability, with +accels, no decels. She had a normal WBC count and her CBC and CMP were normal. She did report lower pelvic pain and urinary frequency, although denies dysuria or hematuria. A urinalysis was suspicious for a UTI so she was treated with 3gm fosfomycin. As she did not meet inpatient hospitalization criteria the monoclonal antibody team was consulted and she elected to receive the infusion. This was given while she was in triage. The patient was advised to return to the hospital with any alarming signs/sxs including severe chest pain, shortness of breath, severe abdominal pain or decreased fetal movement. We discussed quarantining due to Covid and will plan to reschedule her next prenatal visit. She was also taught to administer lovenox and was given her first dose of 40mg SQ. A rx was sent for 40mg BID for 10 days for DVT prophylaxis. She felt comfortable with the plan for discharge and had no further questions.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Blood phosphorus decreased, Blood potassium normal, Blood sodium decreased, Blood urea decreased, C-reactive protein increased
Clinical narrative: Patient hospitalized for 8 hours.  Patient is a 25yo female who presented at 34w0d with fever, tachycardia, and malaise. Given her symptoms a sepsis workup was completed and was given IV fluid resuscitation and oral tylenol. She was found to be positive for Covid 19. After her fluid resuscitation she felt much better. Her vital signs normalized with a heart rate of 88. The fetal heart rate on arrival was tachycardic in the 170's - this also resolved with fluid resuscitation to a baseline of 145-150, moderate variability, with +accels, no decels. She had a normal WBC count and her CBC and CMP were normal. She did report lower pelvic pain and urinary frequency, although denies dysuria or hematuria. A urinalysis was suspicious for a UTI so she was treated with 3gm fosfomycin. As she did not meet inpatient hospitalization criteria the monoclonal antibody team was consulted and she elected to receive the infusion. This was given while she was in triage. The patient was advised to return to the hospital with any alarming signs/sxs including severe chest pain, shortness of breath, severe abdominal pain or decreased fetal movement. We discussed quarantining due to Covid and will plan to reschedule her next prenatal visit. She was also taught to administer lovenox and was given her first dose of 40mg SQ. A rx was sent for 40mg BID for 10 days for DVT prophylaxis. She felt comfortable with the plan for discharge and had no further questions.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray abnormal, Creatinine renal clearance increased, Eosinophil count decreased, Eosinophil percentage decreased
Clinical narrative: Patient hospitalized for 8 hours.  Patient is a 25yo female who presented at 34w0d with fever, tachycardia, and malaise. Given her symptoms a sepsis workup was completed and was given IV fluid resuscitation and oral tylenol. She was found to be positive for Covid 19. After her fluid resuscitation she felt much better. Her vital signs normalized with a heart rate of 88. The fetal heart rate on arrival was tachycardic in the 170's - this also resolved with fluid resuscitation to a baseline of 145-150, moderate variability, with +accels, no decels. She had a normal WBC count and her CBC and CMP were normal. She did report lower pelvic pain and urinary frequency, although denies dysuria or hematuria. A urinalysis was suspicious for a UTI so she was treated with 3gm fosfomycin. As she did not meet inpatient hospitalization criteria the monoclonal antibody team was consulted and she elected to receive the infusion. This was given while she was in triage. The patient was advised to return to the hospital with any alarming signs/sxs including severe chest pain, shortness of breath, severe abdominal pain or decreased fetal movement. We discussed quarantining due to Covid and will plan to reschedule her next prenatal visit. She was also taught to administer lovenox and was given her first dose of 40mg SQ. A rx was sent for 40mg BID for 10 days for DVT prophylaxis. She felt comfortable with the plan for discharge and had no further questions.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Glomerular filtration rate normal, Gram stain positive, Granulocyte percentage, Haematocrit decreased, Haemoglobin decreased
Clinical narrative: Patient hospitalized for 8 hours.  Patient is a 25yo female who presented at 34w0d with fever, tachycardia, and malaise. Given her symptoms a sepsis workup was completed and was given IV fluid resuscitation and oral tylenol. She was found to be positive for Covid 19. After her fluid resuscitation she felt much better. Her vital signs normalized with a heart rate of 88. The fetal heart rate on arrival was tachycardic in the 170's - this also resolved with fluid resuscitation to a baseline of 145-150, moderate variability, with +accels, no decels. She had a normal WBC count and her CBC and CMP were normal. She did report lower pelvic pain and urinary frequency, although denies dysuria or hematuria. A urinalysis was suspicious for a UTI so she was treated with 3gm fosfomycin. As she did not meet inpatient hospitalization criteria the monoclonal antibody team was consulted and she elected to receive the infusion. This was given while she was in triage. The patient was advised to return to the hospital with any alarming signs/sxs including severe chest pain, shortness of breath, severe abdominal pain or decreased fetal movement. We discussed quarantining due to Covid and will plan to reschedule her next prenatal visit. She was also taught to administer lovenox and was given her first dose of 40mg SQ. A rx was sent for 40mg BID for 10 days for DVT prophylaxis. She felt comfortable with the plan for discharge and had no further questions.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Immature granulocyte count, Influenza A virus test negative, Influenza B virus test, Infusion, International normalised ratio normal
Clinical narrative: Patient hospitalized for 8 hours.  Patient is a 25yo female who presented at 34w0d with fever, tachycardia, and malaise. Given her symptoms a sepsis workup was completed and was given IV fluid resuscitation and oral tylenol. She was found to be positive for Covid 19. After her fluid resuscitation she felt much better. Her vital signs normalized with a heart rate of 88. The fetal heart rate on arrival was tachycardic in the 170's - this also resolved with fluid resuscitation to a baseline of 145-150, moderate variability, with +accels, no decels. She had a normal WBC count and her CBC and CMP were normal. She did report lower pelvic pain and urinary frequency, although denies dysuria or hematuria. A urinalysis was suspicious for a UTI so she was treated with 3gm fosfomycin. As she did not meet inpatient hospitalization criteria the monoclonal antibody team was consulted and she elected to receive the infusion. This was given while she was in triage. The patient was advised to return to the hospital with any alarming signs/sxs including severe chest pain, shortness of breath, severe abdominal pain or decreased fetal movement. We discussed quarantining due to Covid and will plan to reschedule her next prenatal visit. She was also taught to administer lovenox and was given her first dose of 40mg SQ. A rx was sent for 40mg BID for 10 days for DVT prophylaxis. She felt comfortable with the plan for discharge and had no further questions.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Lung opacity, Lymphocyte count decreased, Lymphocyte percentage decreased, Malaise, Maternal exposure before pregnancy
Clinical narrative: Patient hospitalized for 8 hours.  Patient is a 25yo female who presented at 34w0d with fever, tachycardia, and malaise. Given her symptoms a sepsis workup was completed and was given IV fluid resuscitation and oral tylenol. She was found to be positive for Covid 19. After her fluid resuscitation she felt much better. Her vital signs normalized with a heart rate of 88. The fetal heart rate on arrival was tachycardic in the 170's - this also resolved with fluid resuscitation to a baseline of 145-150, moderate variability, with +accels, no decels. She had a normal WBC count and her CBC and CMP were normal. She did report lower pelvic pain and urinary frequency, although denies dysuria or hematuria. A urinalysis was suspicious for a UTI so she was treated with 3gm fosfomycin. As she did not meet inpatient hospitalization criteria the monoclonal antibody team was consulted and she elected to receive the infusion. This was given while she was in triage. The patient was advised to return to the hospital with any alarming signs/sxs including severe chest pain, shortness of breath, severe abdominal pain or decreased fetal movement. We discussed quarantining due to Covid and will plan to reschedule her next prenatal visit. She was also taught to administer lovenox and was given her first dose of 40mg SQ. A rx was sent for 40mg BID for 10 days for DVT prophylaxis. She felt comfortable with the plan for discharge and had no further questions.